Eleftherios Spartalis MD MSc PhD FACS
Eleftherios Spartalis MD MSc PhD FACS
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα med.uoa.gr - Αρχική σελίδα
Παρατίθεται από
Παρατίθεται από
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
D Dimitroulis, C Damaskos, S Valsami, S Davakis, N Garmpis, E Spartalis, ...
World journal of gastroenterology 23 (29), 5282, 2017
Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer
C Damaskos, S Valsami, M Kontos, E Spartalis, T Kalampokas, ...
Anticancer research 37 (1), 35-46, 2017
[Comment] COVID-19 pandemic and its impact on mental health of healthcare professionals
K Tsamakis, E Rizos, AJ Manolis, S Chaidou, S Kympouropoulos, ...
Experimental and Therapeutic medicine 19 (6), 3451-3453, 2020
The role of reactive oxygen species in myocardial redox signaling and regulation
D Moris, M Spartalis, E Tzatzaki, E Spartalis, GS Karachaliou, ...
Annals of translational medicine 5 (16), 2017
The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox
D Moris, M Spartalis, E Spartalis, GS Karachaliou, GI Karaolanis, ...
Annals of translational medicine 5 (16), 2017
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, C Abou, ...
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic …
DI Tsilimigras, I Ntanasis-Stathopoulos, F Bagante, D Moris, J Cloyd, ...
Surgical oncology 27 (2), 280-288, 2018
Histone deacetylases as new therapeutic targets in triple-negative breast cancer: Progress and promises
N Garmpis, C Damaskos, A Garmpi, E Kalampokas, T Kalampokas, ...
Cancer genomics & proteomics 14 (5), 299-313, 2017
A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features
EA Trigka, G Levidou, AA Saetta, I Chatziandreou, P Tomos, ...
Oncology reports 30 (2), 623-636, 2013
Oncology during the COVID‑19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients
K Tsamakis, M Gavriatopoulou, D Schizas, A Stravodimou, A Mougkou, ...
Oncology Letters 20 (1), 441-447, 2020
Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective
DI Tsilimigras, I Ntanasis-Stathopoulos, D Moris, E Spartalis, TM Pawlik
Surgical oncology 27 (4), 611-618, 2018
De Garengeot's hernia in a 60-year-old woman: a case report
P Konofaos, E Spartalis, A Smirnis, K Kontzoglou, G Kouraklis
Journal of Medical Case Reports 5 (1), 1-3, 2011
COVID‑19 related stress exacerbates common physical and mental pathologies and affects treatment
K Tsamakis, AS Triantafyllis, D Tsiptsios, E Spartalis, C Mueller, ...
Experimental and therapeutic medicine 20 (1), 159-162, 2020
Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: a systematic review
D Moris, J Chakedis, SH Sun, G Spolverato, DI Tsilimigras, ...
Journal of surgical oncology 117 (3), 341-353, 2018
Solid pseudopapillary tumor of the pancreas: a single-center experience and review of the literature
EA Antoniou, C Damaskos, N Garmpis, C Salakos, GA Margonis, ...
in vivo 31 (4), 501-510, 2017
Delaying surgery for patients with a previous SARS-CoV-2 infection
Journal of British Surgery 107 (12), e601-e602, 2020
Outcomes after open and laparoscopic appendectomy during pregnancy: a meta-analysis
A Prodromidou, N Machairas, ID Kostakis, E Molmenti, E Spartalis, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 225, 40-50, 2018
Hypertension in patients with type 2 diabetes mellitus: Targets and management
DI Pavlou, SA Paschou, P Anagnostis, M Spartalis, E Spartalis, ...
Maturitas 112, 71-77, 2018
The role of NSAIDs in breast cancer prevention and relapse: current evidence and future perspectives
D Moris, M Kontos, E Spartalis, IS Fentiman
Breast Care 11 (5), 339-344, 2016
Updates and critical evaluation on novel biomarkers for the malignant progression of intraductal papillary mucinous neoplasms of the pancreas
D Moris, C Damaskos, E Spartalis, A Papalampros, S Vernadakis, ...
Anticancer research 37 (5), 2185-2194, 2017
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20